Efficacy and safety of degludec versus Glargine in Type 2 Diabetes

S.P. Marso, D.K. Mcguire, B. Zinman, N.R. Poulter, S.S. Emerson, T.R. Pieber, R.E. Pratley, P.-M. Haahr, M. Lange, K. Brown-Frandsen, A. Moses, S. Skibsted, K. Kvist, J.B. Buse

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)723-732
Number of pages10
JournalNew England Journal of Medicine
Volume377
Issue number8
DOIs
Publication statusPublished - 2017
Externally publishedYes

Cite this

Marso, S. P., Mcguire, D. K., Zinman, B., Poulter, N. R., Emerson, S. S., Pieber, T. R., Pratley, R. E., Haahr, P-M., Lange, M., Brown-Frandsen, K., Moses, A., Skibsted, S., Kvist, K., & Buse, J. B. (2017). Efficacy and safety of degludec versus Glargine in Type 2 Diabetes. New England Journal of Medicine, 377(8), 723-732. https://doi.org/10.1056/NEJMoa1615692